Kawakubo K, Kawakami H, Kuwatani M, Haba S, Kawahata S, Abe Y, Kubota Y, Kubo K, Isayama H, Sakamoto N. Recent advances in endoscopic ultrasonography-guided biliary interventions. World J Gastroenterol 2015; 21(32): 9494-9502 [PMID: 26327757 DOI: 10.3748/wjg.v21.i32.9494]
Corresponding Author of This Article
Kazumichi Kawakubo, MD, PhD, Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo 0608638, Japan. kkawakubo-gi@umin.ac.jp
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Kazumichi Kawakubo, Hiroshi Kawakami, Masaki Kuwatani, Shin Haba, Shuhei Kawahata, Yoko Abe, Yoshimasa Kubota, Kimitoshi Kubo, Naoya Sakamoto, Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Sapporo 0608638, Japan
Hiroyuki Isayama, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan
Author contributions: Kawakubo K wrote the manuscript, reviewed the literature and revised the manuscript; Kawakami H and Kuwatani M revised the manuscript; Haba S, Kawahata S, Abe Y, Kubota Y and Kubo K collected the data; Isayama H and Sakaoto N supervised the manuscript; all authors approved the final manuscript for publication.
Conflict-of-interest statement: The authors declared that there is no conflict of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Kazumichi Kawakubo, MD, PhD, Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo 0608638, Japan. kkawakubo-gi@umin.ac.jp
Telephone: +81-11-7161161 Fax: +81-11-7167867
Received: March 18, 2015 Peer-review started: March 19, 2015 First decision: April 23, 2015 Revised: May 15, 2015 Accepted: July 15, 2015 Article in press: July 15, 2015 Published online: August 28, 2015
Abstract
Interventional endoscopic ultrasonography (EUS) based on EUS-guided fine-needle aspiration has rapidly spread as a minimally invasive procedure. Especially in patients with failed endoscopic retrograde cholangiopancreatography, EUS-guided biliary intervention is reported to be useful as salvage therapy. EUS-guided biliary interventions are carried out using three techniques: EUS-guided bilioenteric anastomosis, EUS-guided rendezvous procedure, and EUS-guided antegrade treatment. Although interventional EUS is not yet a standardized procedure, there have been recent advances in this field that address various biliary diseases. Here, we summarize the indications, techniques, clinical results of previous studies, and future perspectives.
Core tip: Endoscopic-ultrasonography-guided biliary drainage (EUS-BD) is widely accepted as salvage therapy for transpapillary treatment. However, there are few data comparing the clinical efficacy of EUS-BD and endoscopic retrograde cholangiopancreatography (ERCP) with regard to which is the treatment of choice. As EUS-BD is performed under direct visualization, it has the potential to replace ERCP. However, a prospective randomized study is necessary to confirm it.
